HOLOGIC INC 4
4 · HOLOGIC INC · Filed Feb 28, 2013
Insider Transaction Report
Form 4
HOLOGIC INCHOLX
SOLTANI PETER
SVP, Breast Health
Transactions
- Exercise/Conversion
Common Stock
2013-02-27$14.50/sh+32,000$464,000→ 88,704 total - Sale
Common Stock
2013-02-27$22.05/sh−32,000$705,600→ 56,704 total - Exercise/Conversion
Common Stock
2013-02-27$13.63/sh+12,000$163,560→ 68,704 total - Sale
Common Stock
2013-02-27$22.02/sh−12,000$264,240→ 56,704 total - Exercise/Conversion
Common Stock
2013-02-27$15.75/sh+24,729$389,482→ 81,433 total - Sale
Common Stock
2013-02-27$22.05/sh−24,729$545,274→ 56,704 total - Exercise/Conversion
Common Stock
2013-02-27$13.87/sh+20,000$277,300→ 76,704 total - Sale
Common Stock
2013-02-27$22.05/sh−20,000$441,000→ 56,704 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2013-02-27−32,000→ 8,000 totalExercise: $14.50Exp: 2015-11-13→ Common Stock (32,000 underlying) - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2013-02-27−12,000→ 8,000 totalExercise: $13.63Exp: 2016-06-22→ Common Stock (12,000 underlying) - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2013-02-27−24,729→ 16,486 totalExercise: $15.75Exp: 2016-11-11→ Common Stock (24,729 underlying) - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2013-02-27−20,000→ 0 totalExercise: $13.87From: 2006-10-31Exp: 2015-10-31→ Common Stock (20,000 underlying)
Footnotes (7)
- [F1]The transaction reported herein reflects an aggregate of sales at prices ranging from $22.01 to $22.085, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the number of shares sold at each separate price.
- [F2]The transaction reported herein reflects an aggregate of sales at prices ranging from $22.01 to $22.06, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the number of shares sold at each separate price.
- [F3]The transaction reported herein reflects an aggregate of sales at prices ranging from $21.99 to $22.16, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the number of shares sold at each separate price.
- [F4]The transaction reported herein reflects an aggregate of sales at prices ranging from $21.99 to $22.152, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the number of shares sold at each separate price.
- [F5]The option becomes exercisable in five equal annual installments beginning November 13, 2009
- [F6]The option becomes exercisable in five equal annual installments beginning June 22, 2010.
- [F7]The option, issued pursuant to the 2008 Equity Incentive Plan, becomes exercisable in five equal annual installments beginning November 11, 2010.